Skip to main content
. 2013 May;20(5):725–731. doi: 10.1128/CVI.00601-12

Table 1.

Oligonucleotides used to amplify the target lig sequences

Antigen used for vaccine preparation Plasmid and oligonucleotidea Amino acidsb Molecular mass (kDa)
LigAni pAE_F, 5′-CCGCTCGAGGATATTCTTACCGTTTC-3′ 629–1224 64
pAE_R, 5′-CGGGAATTCTGGCTCCGTTTTA-3′
pTARGET_F, 5′-ATGGATATTCTTACCGTTTC-3′
LigBni pAE_F, 5′-CCGCTCGAGGATATTGCTGAAATT-3′ 629–1112 52
pAE_R, 5′-CGGGAATTCTCCAGATACTGAACC-3′
pTARGET_F, 5′-ATGCTCGAGGATATTGCTGAAATT-3′
LigBrep pAE_F, 5′-CCGCTCGAGGTGTTTATGAAGAAA-3′ 1–628 72
pAE_R, 5′-ACTCTCGAGCGTATTAGAGGAAT-3′
pTARGET_F, 5′-ATGGTGTTTATGAAGAAAATATTTTTG-3′
LigBct1 pAE_F, 5′-CCGCTCGAGAATACAATCCTCACA-3′ 1113–1501 45
pAE_R, 5′-GGGAAGCTTTATAAAAATATGAGA-3′
pTARGET_F, 5′-ATGAATACAATCCTCACA-3′
LigBct2 pAE_F, 5′-CCGCTCGAGGCAGGTTCAAGACC-3′ 1502–1891 45
pAE_R, 5′-GGGAAGCTTTTATTGATTCTGTT-3′
pTARGET_F, 5′-ATGGCAGGTTCAAGACC-3′
a

In the oligonucleotide sequences, the underlined letters denote the restriction sites.

b

Amino acid coordinates in the LigA and LigB proteins of L. interrogans serovar Copenhageni strain FIOCRUZ L1-130.